Australian student fights cancer with CyberKnife treatment in Turkey
Sonny Guerrini, 20, had developed an Ewing’s sarcoma tumor near his spinal cord. Because of the location of the tumor, conventional radiotherapy had the danger of wreaking undesirable side effects.
Hence, Sonny chose to go for CyberKnife cancer treatment in Turkey which has several major advantages over traditional radiation therapies like Gamma Knife. Medical Tourism Corporation facilitated Sonny’s CyberKnife treatment in Turkey at a very low cost.
For instance, CyberKnife can treat lesions even in areas of the body that move with respiration (like in the case of lung cancer), thanks to advanced image guidance. Also, CyberKnife does not require a head frame screwed into the skull for immobilization, avoiding the pain, headache, nausea, and risk of infection seen sometimes with stereotactic frames like Gamma Knife.
CyberKnife also effectively treats those tumors that were previously thought inoperable, like brain tumors. Other types of cancers that can be treated with CyberKnife are liver, prostate, kidney, liver, neck, spine, lung, and pancreatic cancer.
Sonny, a student at the University of Brisbane, had to go abroad for cancer treatment because Australia doesn’t have a CyberKnife center. Medical Tourism Corporation arranged Sonny’s medical trip to Turkey and took care of his needs at each step. Everything was planned in detail well in advance and Sonny and his family are extremely satisfied with the professionalism of Medical Tourism Corporation and the quality of medical care at Anadolu Medical Center in Turkey.
The cost of CyberKnife treatment in the US can be anywhere between $50,000-$100,000. But Turkey provides very low cost CyberKnife cancer treatment at prices well below $20,000. The quality of the treatment is the same as in the US for the simple reason that the machine used to deliver the treatment is the same. Also, Turkey has very well-qualified and experienced oncologists who speak English fluently. Hence, there is no fear of the low cost of cancer treatment compromising on the quality.